"De Clinical Pharmacology Unit (CPU) is een klinisch onderzoekscentrum verbonden aan Janssen Pharmaceutica NV. We zijn gelegen in het ZNA Jan Palfijn ziekenhuis in Merksem (Antwerpen, België). Janssen CPU speelt een belangrijke rol in de ontwikkeling van zowel nieuwe als bestaande geneesmiddelen. Elk jaar nemen heel wat vrijwilligers deel aan onze klinische studies. Word ook één van hen en help mee aan een gezondere toekomst. Ontvang een vergoeding als je deelneemt. Registreer je op onze website als vrijwilliger voor geneesmiddelenonderzoek of bel ons voor vrijblijvende informatie."

During the past decade, Clinical Pharmacology Unit conducted 53 clinical trials. In the 10-year time frame, 53 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 32 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinical Pharmacology Unit" #1 sponsor was "Janssen Research & Development, LLC" with 38 trials, followed by "Janssen Vaccines & Prevention B.V." with 4 trials sponsored, "Actelion" with 3 trials sponsored, "Janssen-Cilag International NV" with 3 trials sponsored and "Janssen Pharmaceutica N.V., Belgium" with 3 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinical Pharmacology Unit" #1 collaborator was "Bristol-Myers Squibb" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Clinical Pharmacology Unit" are "Healthy" (45 trials), "Alzheimer Disease" (1 trials), "COVID-19 Prevention" (1 trials), "Covid-19 Prevention" (1 trials) and "Crohn Disease" (1 trials). Many other conditions were trialed in "Clinical Pharmacology Unit" in a lesser frequency.

Most popular intervention types in "Clinical Pharmacology Unit" are "Drug" (45 trials), "Biological" (8 trials), "Other" (4 trials), "Diagnostic Test" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (17 trials), "Candin" (3 trials), "Ad26.COV2.S" (2 trials), "Carbamazepine" (2 trials) and "Dextromethorphan 30 mg" (2 trials). Other intervention names were less common.

The vast majority of trials in "Clinical Pharmacology Unit" are 46 trials for "All" genders, 5 trials for "Male" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Clinical Pharmacology Unit". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 46 completed trials in Clinical Pharmacology Unit, 1 suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Clinical Pharmacology Unit, 48 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".